医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Chinese Brand READYOUNG Stuns Paris, Sparking a Craze for Eastern Skincare Culture

2024年09月23日 PM05:37
このエントリーをはてなブックマークに追加


 

SHIJIAZHUANG, China

Following the recent conclusion of the globally anticipated Olympic Games, the 2024 Paris Fashion Week is about to begin, where the convergence of economies and cultures from various countries is ushering in a moment of imminent prosperity. In this vibrant atmosphere, Chinese skincare brand READYOUNG officially made its debut at OPERLE PARFUMERIE in Paris, setting off a wave of beauty and fashion ahead of schedule.

In recent years, with the continuous deepening of globalization and frequent cultural exchanges between countries, products with ethnic characteristics have been gaining resonance and becoming powerful communication tools. Among them, Hanfu (Chinese traditional clothing) and lion dance face masks have captivated audiences worldwide. Meanwhile, the arrival of READYOUNG has lifted the mysterious veil of oriental herbal skincare skills, showcasing the charm of its intangible cultural heritage.

With a history spanning over a thousand years, oriental herbal skincare is a highly valued Eastern heritage of wisdom. This year marks the 60th anniversary of the establishment of diplomatic relations between China and France. In this context, the debut of oriental herbal skincare brand READYOUNG aims to share the essence and achievements of oriental herbal skincare, connecting with the world through skincare culture, and injecting an oriental charm into the brilliance of the fashion capital.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240923692839/en/

CONTACT

READYOUNG

Ms. Kari Li, +86-18331555816

yunduoaiyangad@163.com

Address: Room 07, Floor 07, Innovation Tower Office Building, 585 Tianshan Street, High-Tech Zone, Shijiazhuang, China

Website: http://www.yunduoaiyang.com.cn

同じカテゴリーの記事 

  • スモークフリーの欧州を目指し、イノベーションの重要性を強調するレポートを発表
  • Inocras Unveils Breakthrough Study, Proving Target-Enhanced Whole-Genome Sequencing (TE-WGS) Outperforms Standard Panel Sequencing
  • InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Meet Primary Endpoint in Psoriasis Patients
  • Zai Lab to Present Data from Phase 1 Trial of ZL-1310, Its Investigational Antibody-Drug Conjugate (ADC) for DLL3+ Solid Tumors, at EORTC-NCI-AACR Symposium (ENA) 2024
  • 报告强调了创新对实现“欧盟无烟”的重要作用